Skip to content

A prospective cohort study on the treatment of Sjogren's syndrome by the method of Yiqi Yangyin Quyu

A prospective cohort study on the treatment of Sjogren's syndrome by the method of Yiqi Yangyin Quyu

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070651
Enrollment
Unknown
Registered
2023-04-19
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's syndrome

Interventions

Integrated Chinese and Western Medicine Cohort:N/A
Western medical cohort and Western medical cohort:N/A

Sponsors

The Second Affiliated Hospital, Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Those who meet the diagnostic criteria of Western medicine for dry syndrome. (2) Those who meet the diagnostic criteria of Chinese medicine. (3) Age >= 18 years and <= 75 years. (4) Those who give informed consent.

Exclusion criteria

Exclusion criteria: (1) Those with severe cardiopulmonary insufficiency. (2) Those with serious primary diseases such as liver, kidney and hematopoietic system. (3) Pregnant or lactating women and psychiatric patients.

Design outcomes

Primary

MeasureTime frame
Multidimensional disease activity response;

Secondary

MeasureTime frame
Chinese medicine symptom complex score;ESSDAI;SSDDI;

Countries

China

Contacts

Public ContactChen Mu Zhi

The Second Affiliated Hospital, Zhejiang Chinese Medical University

2545783453@qq.com+86 13738183670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026